|
|
Goldenrod |
|
Goldenrod (English) Solidago
virgaurea (Botanical) Asteraceae or Compositae (Plant
Family) Solidago, Virgaureae herba
(Pharmacopeial)
|
|
| |
|
Overview |
|
Historically, goldenrod has been used topically for wound healing (Kowalchik
and Hylton 1997). In fact, the name, Solidago, the family name for all of
the goldenrod species, is Latin for "to make whole" (Dean 2000; Kowalchik and
Hylton 1997). Goldenrod is a common plant in many parts of the United States. It
has an unusual ability to hybridize, which has created at least 130 recognizable
species in the United States alone (Kowalchik and Hylton 1997; Robbers and Tyler
1999).
Goldenrod is primarily used as an aquaretic agent, meaning that it promotes
the loss of water only (as compared to a diuretic, which promotes the loss of
both water and electrolytes) (Blumenthal et al. 2000). Although goldenrod is a
safe and effective aquaretic, it has not been used as frequently in the U.S. as
in Europe, where it is commonly used to treat urinary tract inflammation, as
well as to prevent or treat kidney stones (Kowalchik and Hylton 1997; Robbers
and Tyler 1999). In fact, most scientific research has focused on European
goldenrod. While the various species of goldenrod are similar in their aquaretic
properties, they may vary in terms of anti-inflammatory and bacteriostatic
properties (Robbers and Tyler 1999).
Goldenrod has also traditionally been used externally for inflammation of the
mouth and pharyngeal cavity, and for the treatment of wounds (Bisset 1994). The
antirheumatic properties associated with goldenrod may be due to
anti-inflammatory and analgesic effects (Klein-Galczinsky 1999). The
anti-inflammatory activity may be attributable to possible antioxidant
properties of the herb (Meyer et al. 1995).
German clinical studies in 1999 compared the anti-inflammatory and analgesic
effects of a fixed phytogenic combination of aspen (Populus tremula),
goldenrod (Solidago virgaurea), and ash (Fraxinus excelsior) with
commonly used nonsteroidal anti-inflammatory drugs (NSAIDs) in patients with
rheumatoid arthritis or osteoarthritis (Klein-Galczinsky 1999). Average doses of
both the combination herbal compound and NSAIDs demonstrated similar
effectiveness for the treatment of these conditions. However, the occurrence of
side effects in patients using the herbal compound was half that experienced by
patients taking NSAIDs. Other studies using the same phytomedicinal combination
of herbal extracts (aspen, goldenrod, and ash) revealed that these herbs may
possess antioxidative properties, which could inhibit free radicals from causing
inflammation (Meyer et al. 1995). Because a combination herbal preparation was
used in these studies, it is not clear whether goldenrod alone would exhibit the
same level of anti-inflammatory and antioxidant activity or whether the results
described are actually due to synergistic effects from all three herbs
together. |
|
|
Macro Description |
|
Goldenrod is most often found along roadsides and in open fields (Kowalchik
and Hylton 1997). European goldenrod, like the many other similar species of
goldenrod, is a perennial with single woody stems that seldom branch and can
grow to heights of three to seven feet. Its yellow flowers, which appear
generally in August and September, are only about 1/4 inch wide, but come in
profuse compound clusters. Leaves alternate between toothed or smooth edges.
While the majority of goldenrod species are native to North America, several
species are common in Europe, Asia, the Azores, and South America.
|
|
|
Part Used/Pharmaceutical
Designations |
|
Dried aerial parts (Hoffman 2000) |
|
|
Constituents/Composition |
|
Goldenrod contains several saponins principally based on polygalic acid
(Bisset 1994; Hoffman 2000; Robbers and Tyler 1999). In addition, clerodane
diterpenes (including solidago lactones I–VII and
elongatolides C and E) have been identified as well as phenolic glycosides such
as leiocarposide, flavonoids such as rutin and quercetin, and miscellaneous
components including anthocyanidins, tannins, polysaccharides, acetylenes,
cinnamates, and hydroxybenzoates. |
|
|
Medicinal
Uses/Indications |
|
Actions: aquaretic, anticatarrhal, anti-inflammatory, antimicrobial,
astringent, diaphoretic, diuretic carminative, mildly antispasmodic (Blumenthal
et al. 1998; Hoffman 2000; Kowalchik and Hylton 1997; Robbers and Tyler
1999)
Traditional Uses: cystitis, urethritis, kidney stones and gravel, arthritis,
periodontal disease, menorrhagia, vomiting, upper respiratory congestion,
influenza, flatulence, dyspepsia, laryngitis, pharyngitis, wound healing, eczema
and other skin conditions (Blumenthal et al. 1998; Hoffman 2000; Kowalchik and
Hylton 1997; Robbers and Tyler 1999)
Solidago virgaurea is used infrequently in Chinese medicine for
dyspepsia, fevers, headaches, measles, and nausea (Duke et al.
1985). |
|
|
Pharmacology |
|
Several animal studies have been performed to isolate the constituents in
goldenrod that are primarily responsible for the aquaretic effect (Robbers and
Tyler 1999). However, because of conflicting data, the results of these studies
are inconclusive. It is possible that the combination of flavonoids and saponins
in goldenrod may contribute to the aquaretic effect. The glycoside leiocarposide
may also play a role. This component has demonstrated significant diuretic
activity in rats, but the diuretic effect was actually reduced in the presence
of flavonoids and/or saponins. In other animal studies, leiocarposide exhibited
anti-inflammatory and analgesic effects (Bisset 1994; Robbers and Tyler 1999).
These effects are thought to be due to the hydrolysis of leiocarposide to
salicylic acid in the intestinal tract.
German studies conducted in 1997 revealed that the triterpenoid saponin
fraction in goldenrod has immunomodulating and antitumor effects (Plohmann et
al. 1997). This component exhibited mitogenic effects in experiments with both
human mononuclear cells and mouse spleen and thymus cells. The clinical
relevance of this finding remains unclear. |
|
|
Dosage Ranges and Duration of
Administration |
|
Infusion or decoction for use as an aquaretic: 2 to 3 tsp of dried herb in 1
cup of water; bring to a boil and let stand for 10 to 15 minutes before
straining and drinking. This preparation should be taken 3 times per day
(Hoffman 2000).
For upper respiratory inflammation: The same infusion described above should
be taken 3 times per day. This infusion can also be used as a gargle for
laryngitis and pharyngitis.
Fluidextract (1:1 in 25% ethanol): 0.5 to 2 ml two to three times per day
(Gruenwald et al. 1998)
Tincture (1:5 in 45% ethanol): 2 to 4 ml two to three times daily (Hoffman
2000)
Copious amounts of water should be taken daily while using goldenrod
(Blumenthal et al. 1998). |
|
|
Side
Effects/Toxicology |
|
The German Commission E reports no known toxicity (Blumenthal et al.
1998).
Contrary to popular belief, goldenrod does not cause hay fever (Dean 2000).
Its pollen grains, which are meant to be carried by insects, are much heavier
than those of ragweed and other plants with airborne pollens that may be
associated with allergies or hay fever. |
|
|
Warnings/Contraindications/Precautions |
|
Goldenrod should not be used as an aquaretic in cases of edema due to
impaired heart or kidney function (Blumenthal et al. 1998).
In vitro studies indicate that the saponin in goldenrod may have spermicidal
effects (Bisset 1994).
While there are no specific restrictions against usage during pregnancy or
breast-feeding, in general it is better to refrain from using any medications
during this time unless absolutely necessary. |
|
|
Interactions |
|
No clinically significant interactions between goldenrod and conventional
medications are known to have been reported in the literature to date, including
the German Commission E monograph for this herb (Blumenthal et al.
1998). |
|
|
Regulatory and Compendial
Status |
|
Goldenrod has been approved by the German Commission E for use as irrigation
therapy in cases of lower urinary tract inflammation (Blumenthal et al. 1998).
In addition, it is approved to prevent and treat urinary calculi or kidney
gravel. |
|
|
References |
|
Bisset NG, ed. Herbal Drugs and Phytopharmaceuticals: A handbook for
practice on a scientific basis. Boca Raton, Fla: CRC Press;
1994:530-533.
Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic
Guide to Herbal Medicines. Boston, Mass: Integrative Medicine
Communications; 1998:139-140.
Blumenthal M, Goldberg A, Brinckmann J, eds. Herbal Medicine: Expanded
Commission E Monographs. Newton, Mass: Integrative Medicine Communications;
2000:178-181.
Dean C. Goldenrod (Solidago). Wildflowers of Alabama. Accessed at
www.auburn.edu/~deancar/wfnotes/gldrd.htm on November 13, 2000.
Duke J, Ayensu, E. Medicinal Plants of China. Algonac, Mich: Reference
Publications; 1985.
el-Ghazaly M, Khayyal MT, Okpanyi SN, Arens-Corell M. Study of the
anti-inflammatory activity of Populus tremula, Solidago
virgaurea and Fraxinus excelsior. Arzneimittelforschung.
1992;42(3):333-336.
Gruenwald J, Brendler T, Jaenicke C, et al., eds. PDR for Herbal
Medicine. Montvale, NJ: Medical Economics Company; 1998.
Hoffman DL. Golden Rod. Herbal Materia Medica. Accessed at
www.healthy.net/library/books/hoffman/materiamedica/goldenrod.htm on November
13, 2000.
Klein-Galczinsky C. Pharmacological and clinical effectiveness of a fixed
phytogenic combination of trembling poplar (Populus tremula), true
goldenrod (Solidago virgaurea) and ash (Fraxinus excelsior) in
mild to moderate rheumatic complaints [in German]. Wien Med Wochenschr.
1999;149(8-10):248-253.
Kowalchik C, Hylton WH, eds. Rodale's Illustrated Encyclopedia of
Herbs. Emmaus, Pa: Rodale Press; 1997:230-231.
Meyer B, Schneider W, Elstner EF. Antioxidative properties of alcoholic
extracts from Fraxinus excelsior, Populus tremula and Solidago
virgaurea. Arzneimittelforschung. 1995;45(2):174-176.
Miller LG, Murray WJ, eds. Herbal Medicinals: A Clinician's Guide. New
York, NY: Pharmaceutical Products Press; 1998.
Plohmann B, Bader G, Hiller K, Franz G. Immunomodulatory and antitumoral
effects of triterpenoid saponins. Pharmazie. 1997;52(12):953-957.
Robbers JE, Tyler VE. Tyler's Herbs of Choice: The Therapeutic Use of
Phytomedicinals. New York, NY: The Haworth Herbal Press; 1999:90-92.
von Kruedener S, Schneider W, Elstner EF. A combination of
Populus tremula, Solidago virgaurea and Fraxinus
excelsior as an anti-inflammatory and antirheumatic drug. A short review.
Arzneimittelforschung.
1995;45(2):169-171. |
|
Copyright © 2000 Integrative Medicine
Communications This publication contains
information relating to general principles
of medical care that should not in any event be construed as specific
instructions for individual patients. The publisher does not accept any
responsibility for the accuracy of the information or the consequences arising
from the application, use, or misuse of any of the information contained herein,
including any injury and/or damage to any person or property as a matter of
product liability, negligence, or otherwise. No warranty, expressed or implied,
is made in regard to the contents of this material. No claims or endorsements
are made for any drugs or compounds currently marketed or in investigative use.
The reader is advised to check product information (including package inserts)
for changes and new information regarding dosage, precautions, warnings,
interactions, and contraindications before administering any drug, herb, or
supplement discussed herein. | |